![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
January 19, 2010 08:00 ET
|
Mymetics Corporation
EPALINGES, Switzerland, Jan. 19, 2010 (GLOBE NEWSWIRE) -- Mymetics Corporation, a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today that following...
![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation Presents Ground Breaking Results With Preventative HIV Vaccine at the World AIDS Vaccine Congress in Paris 19 - 22 October
October 20, 2009 03:00 ET
|
Mymetics Corporation
EPALINGES, Switzerland, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (OTCBB:MYMX), a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today...
![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation Announces the Appointment of Dr. Stanley Plotkin as Chairman of the Scientific Advisory Board and Election of New Members
September 09, 2009 08:30 ET
|
Mymetics Corporation
EPALINGES, Switzerland, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Jacques-Francois Martin, newly appointed President and CEO of Mymetics Corporation (www.mymetics.com) (OTCBB:MYMX), announced today the...
![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation's Board of Directors Announces the Appointment of Jacques-Francois Martin as President and CEO
June 26, 2009 12:18 ET
|
Mymetics Corporation
NYON, Switzerland, June 26, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX), today announced that its Board of Directors has named Jacques-Francois Martin as Chairman of...
Mymetics Corporation Completes Important Acquisition
April 09, 2009 12:15 ET
|
Mymetics Corporation
NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics
(www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has
completed the acquisition of Bestewil Holding B.V. and...
![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation Completes Important Acquisition
April 09, 2009 11:38 ET
|
Mymetics Corporation
NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and its...
Mymetics Corporation Acquires Virosome Biologicals B.V.
March 09, 2009 10:14 ET
|
Mymetics Corporation
This Acquisition Advances Mymetics' Corporate Strategy to Expand Its Vaccine
Portfolio and Enhances Mymetics' Implementation of the Virosome Delivery
Technology
NYON, Switzerland, March 9, 2009...
![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation Acquires Virosome Biologicals B.V.
March 09, 2009 09:56 ET
|
Mymetics Corporation
NYON, Switzerland, March 9, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (www.mymetics.com) (OTCBB:MYMX) announced today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil...
Press Release
February 09, 2009 13:56 ET
|
Mymetics Corporation
Mymetics Corporation verkündet Erfolg ihres Präventivimpfstoffes gegen HIV/AIDS
und Start der europäischen Phase 1 von menschlichen klinischen Studien
NYON, Schweiz, 6. Feb. 2009 (GLOBE NEWSWIRE)...
![Mymetics Corporation](/news-release/logo/217705/0/217705.jpg?lastModified=12%2F09%2F2016%2022%3A51%3A52&size=2)
Mymetics Corporation Announces Success of Its Preventive Vaccine Against HIV/AIDS and Commencement of European Phase 1 Human Clinical Trials
February 09, 2009 09:00 ET
|
Mymetics Corporation
NYON, Switzerland, Feb. 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX), announced today that on February 11, in Montreal, at the 16th world Conference on Retroviruses...